APD356 10 mg + APD356 XR-20 mg + APD356 10 mg matching Placebo + APD356 XR-20 mg matching Placebo + APD356 20 mg + APD356 20 mg matching Placebo + APD356 XR-20 mg (orange tablet) + APD356 XR-20mg (orange tablet, fed state)
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Healthy Subjects
Conditions
Healthy Subjects
Trial Timeline
Jul 1, 2014 → Jan 1, 2016
NCT ID
NCT02192515About APD356 10 mg + APD356 XR-20 mg + APD356 10 mg matching Placebo + APD356 XR-20 mg matching Placebo + APD356 20 mg + APD356 20 mg matching Placebo + APD356 XR-20 mg (orange tablet) + APD356 XR-20mg (orange tablet, fed state)
APD356 10 mg + APD356 XR-20 mg + APD356 10 mg matching Placebo + APD356 XR-20 mg matching Placebo + APD356 20 mg + APD356 20 mg matching Placebo + APD356 XR-20 mg (orange tablet) + APD356 XR-20mg (orange tablet, fed state) is a phase 1 stage product being developed by Eisai for Healthy Subjects. The current trial status is completed. This product is registered under clinical trial identifier NCT02192515. Target conditions include Healthy Subjects.
What happened to similar drugs?
20 of 20 similar drugs in Healthy Subjects were approved
Approved (20) Terminated (1) Active (0)
✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02192515 | Phase 1 | Completed |
Competing Products
20 competing products in Healthy Subjects
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Use of Wearable Digital Sensors After mRNA Vaccination in Adults | Moderna | Preclinical | 0 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| mRNA-6231 | Moderna | Phase 1 | 0 |
| Letrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Isotretinoin | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Fexofenadine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sertraline | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Nizatidine + Axid | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Anastrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-1273.712 | Moderna | Approved | 0 |
| Risperidone | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Metformin + Glucophage | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| Divalproex Sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sirolimus | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Glimepiride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Ziprasidone Hydrochloride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Naproxen sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |